drugset / Trial / NCT06271928
A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging
NaSingle-groupOpen-labelTreatment
Summary
Ovarian aging (OA) seriously affects the physical and mental health of women. Nowadays, Chinese herbs have huge appeal and potential in treating OA. We have created a new Chinese herbal combination Yijing Keli, whereas its safety and efficacy still need to be validated. Hence, we will perform a population-based, multicenter study to confirm the safety and efficacy of Yijing Keli in therapy of OA. We aim to provide a solid evidence for TCM in therapy of OA.
Timeline
- Start
- 2021-10-01
- Primary completion
- 2024-01-01
- Completion
- 2025-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Yijing Keli | Traditional medicine (herbal / TCM) | 2 unknown | Oral |